Relation between body humors and hypercholesterolemia: An iranian traditional medicine perspective based on the teaching of Avicenna

Iranian Red Crescent Medical Journal

Volumn 14, Issue 3, 2012, Pages 133-138

  Emtiazy, M ^a,b   Keshavarz, M ^a   Khodadoost, M ^c   Kamalinejad, M ^d   Gooshahgir, Sa ^b   Shahrad Bajestani, H ^b   Hashem Dabbaghian, F ^b   Alizad, M ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHED UNIVERSITY   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Digestion; Hypercholesterolemia; Iran; Liver; Stomach; Traditional medicine

Indexed keywords

CHOLESTEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; HUMAN; HYPERCHOLESTEROLEMIA; IRAN; MEDICAL LITERATURE; PILOT STUDY; TEMPERAMENT; TRADITIONAL MEDICINE;

EID: 84857807539     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA. Biochemistry. Harper's Illustrated Biochemistry 28 ed. New York: McGraw-Hill Medical, 2010; p. 124.
2. Kamal R, Aleem Sh. Clinical evaluation of the efficacy of a combination of zanjabeel (Zingiber officinale) and amla (Emblica officinalis) in hyperlipidaemia. Indian Journal of Traditional Knowledge 2009;8:413-6.
3. Goldman L AD, eds. Internal Medicine. Cecil Medicine. 23 ed. Philadelphia, PA: Saunders Elsevier, 2008; p. 1546-1555.
4. Derinoz O, Tumer L, Hasanoglu A, Pasaoglu H, Aksakal FN, Ceyhan MN. Cholesterol screening in school children: is family history reliable to choose the ones to screen? Acta Paediatr 2007;96:1794-8. [17971187] [http://dx.doi.org/10.1111/j.1651-2227.2007.00554.x]
5. Pasqui AL, Bova G, Puccetti L, Bruni F, Pompella G, Auteri A. Complement activation in hypercholesterolemia. Nutr Metab Cardiovasc Dis 2000; 10:137-42. [11006922]
6. Jukema JW, Simoons ML. Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol". Acta Cardiol 1999;54:163-8. [10478274]
7. Patel PD, Velazquez JL, Arora RR. Endothelial dysfunction in African- Americans. Int J Cardiol 2009; 132:157-72. [19004510] [http://dx. doi.org/10.1016/j.ijcard.2008.10.007]
8. Pineda J, Marin F, Roldan V, Valencia J, Marco P, Sogorb F. Premature myocardial infarction: clinical profile and angiographic findings. Int J Cardiol 2008;126:127-9. [17462762] [http://dx.doi.org/10.1016/j.ijcard.2007.02.038]
9. Gareus R, Kotsaki E, Xanthoulea S, van der Made I, Gijbels MJ, Kardakaris R, Polykratis A, Kollias G, de Winther MP, Pasparakis M. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 2008;8: 372-83. [19046569] [http://dx.doi. org/10.1016/j.cmet.2008.08.016]
10. Grobbee DE, Bots ML. Statin treatment and progression of atherosclerotic plaque burden. Drugs 2003;63:893-911. [12678574] [http://dx.doi.org/10.2165/00003495-200363090-00004]
11. Underwood RS, Mohiaddin RH. Magnetic resonance imaging of atherosclerotic vascular disease. Am J Hypertens 1993;6:335S-339S. [8297541]
12. Ardissino D, Merlini PA, Ariens R, Coppola R, Bramucci E, Mannucci PM. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet 1997;349:769-71. [9074577] [http://dx.doi.org/10.1016/ S0140-6736(96)11189-2]
13. Emingil G, Buduneli E, Aliyev A, Akilli A, Atilla G. Association between periodontal disease and acute myocardial infarction. J Periodontol 2000;71:1882-6. [11156045] [http://dx. doi.org/10.1902/jop.2000.71.12.1882]
14. Ebrahimi M, Kazemi-Bajestani S, Ghayour-Mobarhan M, Ferns G, Ghayour-Mobarhan M. Coronary Artery Disease and Its Risk Factors Status in Iran: A Review. Iran Red Crescent Med J 2011;13:610-23.
15. Braunwald E, Robert O Bonow. Cardiovascular Medicine. Braunwald's Heart Disease: a Textbook of Cardiovascular Medicine. 9 ed. Philadelphia: Elsevier Saunders, 2012; p. 1-12.
16. Mosinger BJ. Copper-induced and photosensitive oxidation of serum low-density lipoprotein. The relation to cholesterol level and inter-species differences. Biochim Biophys Acta 1995;1270:73-80. [7827139]
17. Anderson JW, Davidson MH, Blonde L, Brown WV, Howard WJ, Ginsberg H, Allgood LD, Weingand KW. Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia. Am J Clin Nutr 2000;71:1433-8. [10837282]
18. Ziegler O, Got I, Jan P, Drouin P. Diet therapy of hypercholesterolemia. From theory to practice. Ann Cardiol Angeiol (Paris) 1989;38:249-53.
19. Bates TR, Connaughton VM, Watts GF. Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother 2009;10:2973-85. [19954271] [http:// dx.doi.org/10.1517/14656560903376186]
20. Seiki S, Frishman WH. Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. Cardiol Rev 2009;17:70-6. [19367148] [http://dx.doi.org/10.1097/CRD.0b013e3181885905]
21. Pascual Cruz M, Chimenos Kustner E, Garcia Vicente JA, Mezquiriz Ferrero X, Borrell Thio E, Lopez Lopez J. Adverse side effects of statins in the oral cavity. Med Oral Patol Oral Cir Bucal 2008;13:E98-101. [18223537]
22. Association AH. Statistical Fact Sheet, Risk Factors. America: National Center for Health Statistics AND National Heart, lung, and Blood 2003-2006; 2010.
23. Laclaustra M, Frangi AF, Frangi AG, Casasnovas JA, Cia P. Association of endothelial function and vascular data with LDL-c and HDL-c in a homogeneous population of middleaged, healthy military men: Evidence for a critical role of optimal lipid levels. Int J Cardiol 2008;125: 376-82. [17477994] [http://dx.doi. org/10.1016/j.ijcard.2007.03.001]
24. Goldman L AD, eds. Internal medicine. Cecil Essential of Medicine. 7 ed. Philadelphia, PA: Saunders Elsevier, 2008; p. 622.
25. Katzung BG. Pharmacology. Basic and clinical Pharmacology. 17 ed: Mc Graw Hill, 2009; p. 612-616.
26. Shi XQ, Lim TK, Lee S, Zhao YQ, Zhang J. Statins alleviate experimental nerve injury-induced neuropathic pain. Pain 2011;152:1033-43. [21414721] [http://dx.doi.org/10.1016/j.pain.2011.01.006]
27. Mammen AL, Pak K, Williams EK, Brisson D, Coresh J, Selvin E, Gaudet D. Anti-HMG-CoA reductase antibodies are rare in statin users, including those with self-limited musculoskeletal side-effects. Arthritis Care Res (Hoboken) 2012;64:269-72. [2197220] [http://dx.doi.org/10.1002/acr.20662]
28. Braunwald E, and Robert O Bonow. Cardiovascular Medicine. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9 ed. Philadelphia: Elsevier Saunders, 2012; p. 1042-1047.
29. WHO Traditional medicine strategy 2002-2005. Geneva: WHO; 2002: 1-3. p. 43-7.
30. Elgood C. History. Iranian Medical history and Lands of the Eastern Caliphate. Tehran: Amir Kabir, 1991; p. 22, 37.
31. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al-Qanun fi al-Tibb. Lebanon:Alamy Le- Al-Matbooat institute, 2005; p. 28-117.
32. Jorjani IIMa-H. Medicine. In: Tajbakhsh H, editor. Al-Aghraz al- Tibb va al- Mabahes al- Alaieah. Tehran: Tehran University, 2006; p. 5-6.
33. Aqili Khorasani SMHIMH. Kholasatol Hekmah. In: Nazem I, editor. Medicine. Qom: Ismaielian, 2006; p. 33.
34. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al-Qanun fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 31-32.
35. Ali SM, Alam M. A scientific correlation between blood groups and temperaments in Unani medicine, 2007.
36. Jorjani IIMa-H. Medicine. In: Tajbakhsh H, editor. Al-Aghraz al- Tibb va al- Mabahes al- Alaieah. Tehran: Tehran University, 2006; p. 11-12.
37. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al-Qanun fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 118.
38. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al-Qanun fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 41.
39. Aqili Khorasani SMHIMH. Medicine. In: Nazem I, editor. Kholasatol Hekmah. Qom:Ismaielian, 2006; p. 57.
40. Jorjani IIMa-H. Medicine. In: Tajbakhsh H, editor. Al-Aghraz al- Tibb va al- Mabahes al- Alaieah. Tehran: Tehran University, 2006; p. 16.
41. Jorjani IIMa-H. Medicine. Zakhirah - E- Kharazm Shahi. Tehran: Bonyade frahange Iran, 1976; p. 12.
42. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al-Qanun fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 30.
43. Zahravi AA-G. Al- Tasrif leman ajeza an AL-Talif Medicine. 1 ed. Tehran: The Institute for Medical History -Islamic and Complementary Medicine, Tehran University of Medical Sciences, 2009; p. 86.
44. Bhat MDA, Khan A, Hakim M. Unani aspect of cardiac arrhythmia-A review. Indian Journal of Traditional Knowledge 2010;9:601-5.
45. Tabei S, Riazi A. Medical sciences in the third millennium: An Avicennian approach. Iran Red Crescent Med J 2009;11:4-9.
46. Hojjati A, Vahdani A. Health Care Accreditation: The Past, Present, and Future in the Middle East. Iran Red Crescent Med J 2010;12:80-1.
47. Shoja MM, Tubbs RS, Loukas M, Khalili M, Alakbarli F, Cohen-Gadol AA. Vasovagal syncope in the Canon of Avicenna: the first mention of carotid artery hypersensitivity. Int J Cardiol 2009;134:297-301. [19332359] [http://dx.doi.org/10.1016/j. ijcard.2009.02.035]
48. Shoja MM, Rashidi MR, Tubbs RS, Etemadi J, Abbasnejad F, Agutter PS. Legacy of Avicenna and evidence-based medicine. Int J Cardiol 2011;150:243-6. [21093081] [http://dx.doi.org/10.1016/j.ijcard.2010.10.019]
49. Ibn Sina AAH. Medicine. In: al-Din. IS, editor. Al-Qanun fi al-Tibb. Lebanon:Alamy Le- Al-Matbooat institute, 2005; p. 173.
50. Maluf L. Dictionary. Al- monjed dictionary(Arabic to Persian). Tehran: Islam publication, 2006; p. 554.
51. Maluf L. Dictionary. Al- monjed dictionary(Arabic to Persian). Tehran: Islam publication, 2006; p. 582.
52. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al- Qanun fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 48.
53. Jorjani IIMa-H. Medicine. In: Tajbakhsh H, editor. Al-Aghraz al- Tibb va al- Mabahes al- Alaieah. Tehran university of Medical Science: Tehran University, 2006; p. 103.
54. Arzani HMA. Medicine. In: institute ETT, editor. Tibb akbari. 1 ed. Qom: Jalal al-Din, 2008; p. 15.
55. Sabzevari MH. Philosophy. Sharhe Almanzumah. Qom: Noor al- Hekmah institute, 2010; p. 86.
56. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al-Qanon fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 46.
57. Ahmad T, Anwar M. Clinical importance of leech therapy. Indian Journal of Traditional Knowledge 2009;8:443-5.
58. Ibn Nafis AOAa-HAIAa-H. Medicine. Moalejate Ibn Nafis. Tehran university of Medical Science: Institute for Islamic and Complementary Medicine, 2004; p. 318.
59. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al- Qanun fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 128-131.
60. Ibn Sina AAH. Medicine. In: al-Din IS, editor. Al-Qanun fi al-Tibb. Lebanon: Alamy Le- Al-Matbooat institute, 2005; p. 53-54.
61. Aqili Khorasani SMHIMH. Medicine. In: Nazem I, editor. Kholasatol Hekmah. Qom: Ismaielian, 2006; p. 1352.
62. Aqili Khorasani SMHIMH. Medicine. Moalejate Aghili. Tehran university of Medical Science: Institute for Islamic and Complementary Medicine, 2008; p. 602-603.
63. Chashti HMAK. Medicine. Exir-e- Azam. Tehran university of Medical Science:Institute for Islamic and Complementary Medicine, 2007; p. 347-348.
64. Kermani NIE. Medicine. In: institute ETT, editor. Sharhe Asbaab-o- Alaamaat of Samarghandi. Qom: Jalal al- Din, 2008; p. 604.
65. Jorjani IIMa-H. Medicine. Zakhirah - E- Kharazm Shahi. Tehran: Bonyade frahange Iran, 1976; p. 430.
66. Zahravi A. Medicine. Al- Tasrif- Le man ajeza an talif. Tehran university of Medical Science: Institute for Islamic and Complementary Medicine, 2009; p. 566-567.
67. Choopani R, Emtiazy M, Tansaz M, Khodadoost M. Medicine. Asbab va Alayem (Symptoms and Diagnosis of Diseases in the Iranian Traditional Medicine). Tehran: Faraz andishe sabz, 2009; p. 114-115.